Case Report
Year 2021,
Volume: 43 Issue: 1, 97 - 99, 31.03.2021
Abstract
References
- 1- Gedikli, M. A., Tuzun, B., Aktas, A., Sayin, K., & Ataseven, H. (2021). Areclarithromycin, azithromycinandtheiranalogueseffective in thetreatment of COVID19?. Bratislavskelekarskelisty, 122(2), 101-110.
- 2- Aktas, A., Tuzun, B., Taskin, A. H., Sayin, K. O. R. A. Y., & Ataseven, H. (2020). How do arbidolanditsanalogsinhibitthe SARS-CoV-2?. Bratislavskelekarskelisty, 121(10), 705-711.
- 3- Aktaş, A.,Sener, K., Yılmaz, N., Tunç, M., & Yolcu, S. (2020). Is MeanPlatelet Volume UsefulforPredictingthePrognosis of COVID-19 DiagnosedPatients?. Age, 54(18,191), 18-191.
- 4- Huzmeli, C., Candan, F., Bagci, G., Alaygut, D., Yilmaz, A., Gedikli, A., ... &Kayatas, M. (2017). Frequency of familialMediterraneanfever (MEFV) gene mutations in patientswithbiopsy-provenprimaryglomerulonephritis. Clinicalrheumatology, 36(11), 2589-2594.
- 5- Becker, R. C. (2020). COVID-19-associated vasculitisandvasculopathy.
- 6- Iba, T.,Connors, J. M., &Levy, J. H. (2020). Thecoagulopathy, endotheliopathy, andvasculitis of COVID-19. InflammationResearch, 1-9.
Year 2021,
Volume: 43 Issue: 1, 97 - 99, 31.03.2021
Abstract
This disease, which is called COVID-19 disease due to the SARS COV2 virus, which emerged as a result of the mutation of the coronavirus in China in 2019, and caused significant morbidity and mortality all over the world due to the pandemic it created, has become the world's most important health problem. COVID-19 clinic emerges in a wide spectrum from mild viral infection to severe respiratory failure. COVID-19 is thought to be a syndrome that involves multiple organs and systems in various ways, especially endothelial damage.With this case, we wanted to emphasize that this virus is not only isolated in the respiratory system and should be kept in mind in today's conditions among the rare causes of vasculitis.
Keywords
References
- 1- Gedikli, M. A., Tuzun, B., Aktas, A., Sayin, K., & Ataseven, H. (2021). Areclarithromycin, azithromycinandtheiranalogueseffective in thetreatment of COVID19?. Bratislavskelekarskelisty, 122(2), 101-110.
- 2- Aktas, A., Tuzun, B., Taskin, A. H., Sayin, K. O. R. A. Y., & Ataseven, H. (2020). How do arbidolanditsanalogsinhibitthe SARS-CoV-2?. Bratislavskelekarskelisty, 121(10), 705-711.
- 3- Aktaş, A.,Sener, K., Yılmaz, N., Tunç, M., & Yolcu, S. (2020). Is MeanPlatelet Volume UsefulforPredictingthePrognosis of COVID-19 DiagnosedPatients?. Age, 54(18,191), 18-191.
- 4- Huzmeli, C., Candan, F., Bagci, G., Alaygut, D., Yilmaz, A., Gedikli, A., ... &Kayatas, M. (2017). Frequency of familialMediterraneanfever (MEFV) gene mutations in patientswithbiopsy-provenprimaryglomerulonephritis. Clinicalrheumatology, 36(11), 2589-2594.
- 5- Becker, R. C. (2020). COVID-19-associated vasculitisandvasculopathy.
- 6- Iba, T.,Connors, J. M., &Levy, J. H. (2020). Thecoagulopathy, endotheliopathy, andvasculitis of COVID-19. InflammationResearch, 1-9.
There are 6 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Reports |
| Authors | |
| Publication Date | March 31, 2021 |
| Acceptance Date | March 26, 2021 |
| Published in Issue | Year 2021Volume: 43 Issue: 1 |